Live monovalent A/California/66/395 (H2N2) influenza vaccine

influenza vaccine (live attenuated monovalent H2N2) · PATH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Live monovalent A/California/66/395 (H2N2) influenza vaccine, covering 2019-02-06 to 2019-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/CALIFORNIA/66/395 (H2N2) Influenza Vaccine [Phase 1]

See pricing